广东药科大学学报2017，Vol.33Issue(4)：565-569,5.DOI:10.16809/j.cnki.2096-3653.2017030501
非瑟酮抗肿瘤药理、药动学及新剂型研究进展
Advance on pharmacology, pharmacokinetics and particulate formulation of Fisetin
陈锐娥 1陈文荣 2龙晓英3
作者信息
- 1. 中山大学新华学院 药学系,广东 广州510520
- 2. 仙乐健康科技股份有限公司,广东 汕头515000
- 3. 广东药科大学 中药学院,广东 广州510006
- 折叠
摘要
Abstract
The pharmacokinetics characteristics and new dosage forms of Fisetin is reviewed here. The particulate formulations such as inclusion complex, liposomes and nanoparticles for improving bioavailability and anti-tumor activities of Fisetin are summarized, which may offer some new ideas for further research and development on anti-tumor treatment.关键词
非瑟酮/抗肿瘤/药动学/新剂型Key words
Fisetin/anti-tumor/pharmacokinetics/particulate formulation分类
医药卫生引用本文复制引用
陈锐娥,陈文荣,龙晓英..非瑟酮抗肿瘤药理、药动学及新剂型研究进展[J].广东药科大学学报,2017,33(4):565-569,5.
